Accenture Americas CEO sells 14 shares in plan

Accenture plc CEO-The Americas John F. Walsh reported small planned share sales under a Rule 10b5-1 trading plan.

Rhea-AI Filing Summary

Accenture plc CEO-The Americas John F. Walsh reported small planned share sales under a Rule 10b5-1 trading plan. On February 4, 2026, he sold a total of 14 Class A ordinary shares in several trades at weighted average prices between $235.765 and $244.4767, leaving him with 24,972 shares directly owned.

Insider Trade Summary

Net Seller: 14 shares

Net Sell 4 txns

Insider Walsh John F

Role CEO-The Americas

Sold 14 shs ($3K)

Type	Security	Shares	Price	Value
Sale	Class A ordinary shares	2	$235.765	$471.53
Sale	Class A ordinary shares	5	$242.193	$1K
Sale	Class A ordinary shares	4	$243.165	$972.66
Sale	Class A ordinary shares	3	$244.4767	$733.43

Holdings After Transaction: Class A ordinary shares — 24,972 shares (Direct)

Footnotes (5)

1. F1. Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan.
2. F2. The transaction was executed in multiple trades at prices ranging from $235.425 to $236.105. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. F3. The transaction was executed in multiple trades at prices ranging from $241.65 to $242.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
4. F4. The transaction was executed in multiple trades at prices ranging from $242.895 to $243.765. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
5. F5. The transaction was executed in multiple trades at prices ranging from $244.195 to $244.83. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Accenture (ACN) report for John F. Walsh?

John F. Walsh, Accenture’s CEO-The Americas, reported selling 14 Class A ordinary shares. The sales occurred in several small trades on February 4, 2026, and were disclosed as part of a pre-arranged Rule 10b5-1 trading plan.

When did John F. Walsh’s latest Accenture (ACN) share sales take place?

The reported Accenture share sales by John F. Walsh took place on February 4, 2026. All disclosed transactions on this Form 4 occurred on that date and involved non-derivative Class A ordinary shares sold in multiple small trades.

How many Accenture (ACN) shares did John F. Walsh sell in this Form 4?

John F. Walsh sold a total of 14 Accenture Class A ordinary shares. The Form 4 breaks this into four separate transactions of 2, 5, 4, and 3 shares each, all recorded as sales on February 4, 2026.

At what prices were John F. Walsh’s Accenture (ACN) shares sold?

The reported sales used weighted average prices of $235.765, $242.193, $243.165, and $244.4767 per share. Footnotes explain that each sale was executed in multiple trades within narrow price ranges around those averages.

How many Accenture (ACN) shares does John F. Walsh own after these sales?

After the reported transactions, John F. Walsh directly owns 24,972 Accenture Class A ordinary shares. This figure reflects his beneficial ownership immediately following the final sale reported on February 4, 2026.

Were John F. Walsh’s Accenture (ACN) share sales under a Rule 10b5-1 plan?

Yes. A footnote states the disposition of Accenture Class A ordinary shares was made pursuant to a Rule 10b5-1 trading plan. Such plans pre-schedule trades, helping separate routine diversification from discretionary insider sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/05/2026 - 04:16 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Walsh John F

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO-The Americas

3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	02/04/2026		S(1)		2	D	$235.765(2)	24,984	D
Class A ordinary shares	02/04/2026		S(1)		5	D	$242.193(3)	24,979	D
Class A ordinary shares	02/04/2026		S(1)		4	D	$243.165(4)	24,975	D
Class A ordinary shares	02/04/2026		S(1)		3	D	$244.4767(5)	24,972	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan.

2. The transaction was executed in multiple trades at prices ranging from $235.425 to $236.105. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. The transaction was executed in multiple trades at prices ranging from $241.65 to $242.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

4. The transaction was executed in multiple trades at prices ranging from $242.895 to $243.765. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

5. The transaction was executed in multiple trades at prices ranging from $244.195 to $244.83. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

	/s/ Danika Haueisen, Attorney-in-Fact for John F. Walsh	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.